Amissa empowers healthcare providers and researchers to easily collect, analyze, and act on Apple Watch data from both patients and study participants. No more data overload—just the key insights you need to drive better outcomes and groundbreaking discoveries.
On average, perimenopause lasts four years, but can continue for up to eight years until women finally reach menopause. Approximately 1.3 million U.S. women become menopausal each year. Yet, research in this area has been underfunded — leading to significant lack of understanding of symptoms and effective treatments. Women are anxious for guidance and solutions as they go through that phase of life. Amissa is partnering with patients and providers to develop next generation digital biomarkers to close the gaps in our understanding of perimenopause and improve individualized treatment.
An estimated 6.7 million Americans over 65 are living with Alzheimer’s disease, and almost two-thirds of these are women. Researchers are now finding connections between hormonal changes and lifestyle interruptions that occur during menopause and may link to a dementia diagnosis. Amissa has developed machine learning models that predict preclinical Alzheimer’s disease based upon Apple Watch data. We continue to partner with leading research institutions to understand dementia and cognitive decline.
